Artelo Biosciences Inc. (NASDAQ:ARTL) currently has a daily average trading volume of 407.16K but it saw 6674473 shares traded on Wednesday. With a market cap of 4.92M USD. Stock’s current market price of $1.10 came rising about 25.00 while comparing to the previous closing price of $0.88. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.42 and as low as $0.61. In the recent trading on the day, stock has struck highest price mark of $1.30 while lowest mark touched by it was $0.8784.
Taking a look at 20-day trading activity of Artelo Biosciences Inc. (ARTL) gives us an average price of $1.1170, while its current price level is -75.13% below from 52-week high level whereas it is 80.33% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.2017 while that of 200 days or SMA-200 reads an average of $1.5493. A closer look into the stock’s movement over the week reveals that its volatility is standing at 18.02% during that period while stretching the period over a month that decreases to 10.87%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 49.29 which implies that the stock is in neutral territory.
Artelo Biosciences Inc. (ARTL)’s stock is currently under the radar of 1 analysts who are in consensus at a 12-month price target range of between $8.00 and $8.00 for company’s shares. The average price target assigned by the average number of analysts to a stock is a way to gauge worth of any stock in next 52 weeks. And in assigning price target to a stock, some analysts adopt a bearish approach by advocating lower-than-average price target which in this case is $8.00 while some adopt bullish approach by assigning higher-than-average price target which reads the price to top $8.00. Average price target assigned by them is $8.00 which highlights an upside potential of 86.25% for the stock over that period. And to attain the median price target of $8.00 assigned by those analysts, stock has to add about 86.25% of value to its current levels.
Data by FactSet Research shows that 1 analysts have issued their ratings for the stock. 0 of them are in opinions that stock is a Sell, while 0 are advising it as an Overweight. 0 analysts suggested the investors to Buy the stock while 1 advised them to Hold. Recommendations by all of those brokerages imply a consensus rating of Hold for the stock and that issued by Wall Street to investors is Hold.
Over the week, ARTL’s stock price is moving 0.92% up while it is -2.65% when we observe its performance for the past one month. Year-to-date it is -59.26% down and over the past year, the stock is showing a downside performance of -43.59%.
The latest quarterly earnings report issued by the company was for quarter ended 5/30/2020, when its quarterly earnings per share (EPS) of -$0.27 beat the consensus estimate of -$0.4 for the same. The company is expected to be releasing its next quarterly report in 11/23/2020, for which analysts forecasted an EPS of -$0.36 while estimate for next year EPS is -$1.65. For ARTL, analysts are forecasting an EPS-growth rate of -65.00% for current year and estimate for EPS growth in next year is 0.60%.
Currently, Artelo Biosciences Inc.’s total number of outstanding shares is 3.47M with 14.55% of that held by the insiders while 0.23% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -103.10%. Stock has a price to book (P/B) ratio of 1.18. Its return on asset (ROA) is -90.90% on average.